Compare J.B.Chemicals with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs STERLING BIOTECH - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS STERLING BIOTECH J.B.CHEMICALS/
STERLING BIOTECH
 
P/E (TTM) x 16.8 -0.4 - View Chart
P/BV x 2.3 0.0 16,294.6% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 J.B.CHEMICALS   STERLING BIOTECH
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
STERLING BIOTECH
Dec-13
J.B.CHEMICALS/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs36311 3,458.1%   
Low Rs2553 7,500.0%   
Sales per share (Unadj.) Rs169.126.8 631.0%  
Earnings per share (Unadj.) Rs16.6-15.0 -111.0%  
Cash flow per share (Unadj.) Rs23.4-5.5 -428.7%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs172.554.9 314.3%  
Shares outstanding (eoy) m83.57267.87 31.2%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.80.3 704.8%   
Avg P/E ratio x18.6-0.5 -4,006.8%  
P/CF ratio (eoy) x13.2-1.3 -1,037.4%  
Price / Book Value ratio x1.80.1 1,414.8%  
Dividend payout %12.00-   
Avg Mkt Cap Rs m25,8271,862 1,387.3%   
No. of employees `0003.81.4 278.6%   
Total wages/salary Rs m2,511547 459.2%   
Avg. sales/employee Rs Th3,747.45,303.3 70.7%   
Avg. wages/employee Rs Th665.7403.8 164.8%   
Avg. net profit/employee Rs Th367.8-2,959.0 -12.4%   
INCOME DATA
Net Sales Rs m14,1357,181 196.8%  
Other income Rs m36643 858.7%   
Total revenues Rs m14,5017,223 200.8%   
Gross profit Rs m2,178947 230.0%  
Depreciation Rs m5702,543 22.4%   
Interest Rs m354,377 0.8%   
Profit before tax Rs m1,940-5,931 -32.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m552-1,924 -28.7%   
Profit after tax Rs m1,387-4,007 -34.6%  
Gross profit margin %15.413.2 116.9%  
Effective tax rate %28.532.4 87.8%   
Net profit margin %9.8-55.8 -17.6%  
BALANCE SHEET DATA
Current assets Rs m10,47014,335 73.0%   
Current liabilities Rs m2,74949,809 5.5%   
Net working cap to sales %54.6-494.0 -11.1%  
Current ratio x3.80.3 1,323.4%  
Inventory Days Days55403 13.7%  
Debtors Days Days78171 45.5%  
Net fixed assets Rs m5,81155,432 10.5%   
Share capital Rs m167268 62.4%   
"Free" reserves Rs m14,24813,935 102.2%   
Net worth Rs m14,41614,701 98.1%   
Long term debt Rs m09,478 0.0%   
Total assets Rs m17,64973,988 23.9%  
Interest coverage x56.6-0.4 -15,937.8%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.80.1 825.2%   
Return on assets %8.10.5 1,608.7%  
Return on equity %9.6-27.3 -35.3%  
Return on capital %13.7-6.4 -213.1%  
Exports to sales %025.9 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m6,1641,860 331.4%   
Fx outflow Rs m1,33425 5,361.3%   
Net fx Rs m4,8291,835 263.2%   
CASH FLOW
From Operations Rs m1,2311,719 71.6%  
From Investments Rs m-208-3,148 6.6%  
From Financial Activity Rs m-5951,426 -41.7%  
Net Cashflow Rs m427-3 -12,561.8%  

Share Holding

Indian Promoters % 55.4 33.9 163.4%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 0.0 -  
FIIs % 3.9 9.9 39.4%  
ADR/GDR % 0.0 16.9 -  
Free float % 37.0 39.3 94.1%  
Shareholders   30,437 21,482 141.7%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   ELDER PHARMA  FDC LTD.  SHASUN PHARMA  DISHMAN PHARMA  TTK HEALTHCARE  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Sep 20, 2019 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS